Ardelyx, Inc. (ARDX)
3.34
-0.04
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
3.335
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Shareholders Equity (Quarterly) : 149.01M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 149.01M |
| March 31, 2026 | 148.62M |
| December 31, 2025 | 166.95M |
| September 30, 2025 | 154.28M |
| June 30, 2025 | 139.53M |
| March 31, 2025 | 145.68M |
| December 31, 2024 | 173.29M |
| September 30, 2024 | 158.30M |
| June 30, 2024 | 146.99M |
| March 31, 2024 | 150.89M |
| December 31, 2023 | 166.82M |
| September 30, 2023 | 191.16M |
| June 30, 2023 | 123.16M |
| March 31, 2023 | 125.42M |
| December 31, 2022 | 98.33M |
| September 30, 2022 | 66.86M |
| June 30, 2022 | 53.04M |
| March 31, 2022 | 64.19M |
| December 31, 2021 | 82.62M |
| September 30, 2021 | 81.43M |
| June 30, 2021 | 117.57M |
| March 31, 2021 | 130.81M |
| December 31, 2020 | 126.11M |
| September 30, 2020 | 131.34M |
| June 30, 2020 | 146.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 167.76M |
| December 31, 2019 | 186.66M |
| September 30, 2019 | 49.16M |
| June 30, 2019 | 68.62M |
| March 31, 2019 | 91.84M |
| December 31, 2018 | 115.81M |
| September 30, 2018 | 141.45M |
| June 30, 2018 | 163.41M |
| March 31, 2018 | 128.98M |
| December 31, 2017 | 139.31M |
| September 30, 2017 | 126.64M |
| June 30, 2017 | 144.98M |
| March 31, 2017 | 167.68M |
| December 31, 2016 | 193.15M |
| September 30, 2016 | 222.89M |
| June 30, 2016 | 140.60M |
| March 31, 2016 | 167.75M |
| December 31, 2015 | 108.90M |
| September 30, 2015 | 125.13M |
| June 30, 2015 | 142.26M |
| March 31, 2015 | 58.00M |
| December 31, 2014 | 60.68M |
| September 30, 2014 | 63.30M |
| June 30, 2014 | 62.87M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 246.22M |
| REGENXBIO, Inc. | 71.76M |
| Compass Therapeutics, Inc. | 166.05M |
| ARS Pharmaceuticals, Inc. | 12.51M |
| Sionna Therapeutics, Inc. | 265.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 575.89M |
| Total Liabilities (Quarterly) | 426.88M |
| Debt to Equity Ratio | 1.719 |
| Current Ratio | 3.342 |
| Net Debt Paydown Yield | -1.59% |